Abstract

Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2020 - Volume 24, Number 1

Page(s): 38-43

Download in electronic PDF format for $75
  • Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Page 1
  • Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Page 2
  • Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Page 3
  • Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Page 4
  • Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Page 5
  • Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Page 6

Abstract

Pharmaceutical formulation involves patient acceptability and compliance, ease of preparation, microbiological considerations, and chemical and physical factors affecting compatibility of all ingredients and stability. Physical factors such as light, heat, and humidity can trigger or accelerate undesirable chemical reactions such as oxidation, hydrolysis, decarboxylation, racemization, and photolysis, compromising drug stability. Many drug products and preparations are subject to oxidation, which can often be catalyzed by light, temperature, hydrogen ion concentration, presence of trace metals, or peroxides. Oxidation of a product may be manifested as an unpleasant odor or taste, discoloration or other change in appearance, precipitation, or even a slight loss of activity. Antioxidants are often introduced to improve the shelf life of pharmaceuticals along with suggested procedures to minimize oxidation. Often, chelating agents are added with antioxidants to bind with any trace metals present and enhance the stability of the formulation.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2020
Pg. 38-43
Author(s): Allen Loyd V Jr
Jul/Aug 2017
Pg. 301-308
Author(s): Akers Michael J
Jul/Aug 2001
Pg. 310-312
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 295-302
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 206-212
Author(s): Allen Loyd V Jr
Jul/Aug 2019
Pg. 305-311
Author(s): Allen Loyd V Jr
Sep/Oct 2020
Pg. 388-395
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 137-141
Author(s): Akers Michael J
Sep/Oct 2021
Pg. 396-400
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 304-309
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 118-126
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 446-466
Author(s): Allen Loyd V Jr
Jan/Feb 2016
Pg. 41-45
Author(s): Akers Michael J
May/Jun 2017
Pg. 223-228
Author(s): Akers Michael J
Sep/Oct 2018
Pg. 387-398
Nov/Dec 2021
Pg. 486-489
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Mar/Apr 2020
Pg. 114-118
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 472-477
Author(s): Allen Loyd V Jr
Sep/Oct 2019
Pg. 399-402
Author(s): Allen Loyd V Jr